肝硬化并发肾损伤早期检测指标的研究进展

路丽芳; 冯国和

doi:10.3969/j.issn.1001-5256.2016.09.037

肝硬化并发肾损伤早期检测指标的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.09.037

中国医科大学附属盛京医院感染科

详细信息

中图分类号: R692;R575.2
计量
- 文章访问数: 2055
- HTML全文浏览量: 10
- PDF下载量: 488
- 被引次数: 0
出版历程
- 收稿日期: 2016-04-15
- 出版日期: 2016-09-20

Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment

Department of Infectious Diseases,Shengjing Hospital of China Medical University

摘要

摘要: 肝脏与肾脏关系密切,不同时期肝损伤均可发生不同程度及种类的肾脏疾病而导致肾损伤。此类肾损伤早期往往呈功能性,如果及时发现则可在药物作用下发生逆转,反之可发展为肝肾综合征或导致急性肾衰竭而危及生命。血清肌酐以及尿素氮等检测指标对肾损伤的早期诊断性能极为有限,难以达到对肝硬化患者合并肾损伤的早期监测及诊断。因此如何对肝硬化患者并发肾损伤进行早期监测,一直是该领域研究的热点。总结了近5年有关反映肾损伤早期检测指标的研究进展。
- 肝硬化 /
- 肾疾病 /
- 诊断 /
- 综述
Abstract: The liver is closely associated with the kidney,and liver injury in various stages can cause various kidney diseases to varying degrees,which further lead to renal impairment. Such renal impairment in the early stage is often functional and can be reversed by drugs,otherwise it can progress to hepatorenal syndrome,cause acute renal failure,and even threaten human life. The indicators such as serum creatinine and urea nitrogen have a limited effect in the early diagnosis of renal impairment and cannot be used for early monitoring and diagnosis of liver cirrhosis patients with renal impairment. Therefore,early monitoring of liver cirrhosis patients with renal impairment has always been a hot topic in this field. This article summarizes the research advances in the indicators for early diagnosis of renal impairment.
- liver cirrhosis /
- kidney diseases /
- diagnosis /
- review

HTML全文

参考文献(35)

[1]CHEN YC,SU YC,LI CY,et al.13-year nationwide cohort study of chronic kidney disease risk among treatment-na6ve patients with chronic hepatitis B in Taiwan[J].BMC Nephrol,2015,16:110.

[2]ZUO L,SUN FX,WANG XB,et al.Clinical analysis of 298 cases of liver cirrhosis and renal dysfunction[J].Chin J Hepatol,2014,22(7):504-508.(in Chinese)左璐,孙凤霞,王宪波,等.298例乙型肝炎肝硬化患者合并肾功能不全情况分析[J].中华肝脏病杂志,2014,22(7):504-508.

[3]ASKENAZI D.Are we ready for the clinical use of novel acute kidney injury biomarkers?[J].Pediatr Nephrol,2012,27(9):1423-1425.

[4]URRUNAGA NH,MINDIKOGLU AL,ROCKEY DC.Renal dysfunction in cirrhosis[J].Curr Opin Gastroenterol,2015,31(3):215-223.

[5]HSIAO PG,HSIEH CA,YEH CF,et al.Early prediction of acute kidney injury in patients with acute myocardial injury[J].J Crit Care,2012,27(5):525.e1-e7.

[6]RUIZ-DEL-RBO L,ACHECAR L,SERRADILLA R,et al.Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis,portal hypertension,and a normal creatinine[J].Hepatology,2013,58(5):1732-1741.

[7]TSIEN CD,RABIE R,WONG F.Acute kidney injury in decompensated cirrhosis[J].Gut,2013,62(1):131-137.

[8]KOSTRUBIEC M,LABYK A,PEDOWSKA-WIOSZEK J,et al.Neutrophil gelatinase-associated lipocalin,cystatin C and e GFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism[J].Heart,2012,98(16):1221-1228.

[9]MURTY MS.Serum cystatin C as a marker of renal function in detection of early acute kidney injury[J].Indian J Nephrol,2013,23(3):180-183.

[10]HAHN WH,BAE CW.Reference intervals of serum cystatin C/creatinine ratio of 30 postnatal days in neonates[J].Pediatr Nephrol,2013,28(9):1420-1423.

[11]ASSAL HS,TAWFEEK S,RASHEED EA,et al.Serum cystatinc and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus[J].Clinical Med Insights,2013,6(5):7-13.

[12]STEVENS LA,SCHMID CH,GREENE T,et al.Factors other than glomerular filtration rate affect serum cystatin C levels[J].Kidney Int,2009,75(6):652-660.

[13]INKER LA,SCHMID CH,TIGHIOUART H,et al.Estimating glomerular filtration rate from serum creatinine and cystatin C[J].N Engl,J Med,2012,367(1):20-29.

[14]JONAS B,ANDERS G,ANDERS L,et al.Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays:a cross-sectional study in sweden[J].Clin Chem Lab Med,2015,53(3):403-414.

[15]ZHU Y,YE XH,ZHU B,et al.Comparisons between the 2012new CKDEPI(chronic kidney disease epidemiologycollaboration)equations and other four approved equations[J].PLo S One,2014,9(1):e84688.

[16]MINDIKOGLU AL,DOWLING TC,WEIR MR,et al.Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis[J].Hepatology,2014,59(4):1532-1542.

[17]KRONES E,FICKERT P,ZITTA S,et al.The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis[J].BMC Nephrology,2015,16(1):196.

[18]PARAGAS N,QIU A,HOLLMEN M,et al.NGAL-Siderocalin in kidney disease[J].Biochim Biophys Acta,2012,1823(9):1451-1458.

[19]HAASE-FIELITZ A,HAASE M,DEVARAJAN P,et al.Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury:a critical evaluation of current status[J].Ann Clin Biochem,2014,51(Pt 3):335-351.

[20]HEISE D,RENTSCH K,BRAEUER A,et al.Comparison of urinary neutrophil glucosaminidase-associated lipocalin,systatin C,andα1-microglobulin for early detection of acute renal injury after cardiac surgery[J].Eur J Cardiothorac Surg,2011,39(1):38-43.

[21]MARTENSSON J,BELLOMO R.The rise and fall of NGAL acute kidney injury[J].Blood Purif,2014,37(4):304-310.

[22]NICKOLAS TL,FORSTER CS,SISE ME,et al.NGAL(Lcn2)monomer is associated with tubulointerstitial damage in chronic kidney disease[J].Kidney Int,2012,82(6):718-722.

[23]WONG F,O'LEARY JG,REDDY KP,et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patient with cirrhosis and infection[J].Gastroenterology,2013,145(6):1280-1288.

[24]WAN ZH,WANG JJ,XIE GM,et al.Significance of serum cystatin C level for early diagnosis of acute kidney injury in patients with acute-on-chronic liver ailure[J].J Clin Hepatol,2014,30(7):666-669.

[25]LIU KD,YANG W,ANDERSON AH,et al.Urineneutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease[J].Kidney Int,2013,83(5):909-914.

[26]DONADIO C.Effect of glomerular filtration rate impairment on diagnostic performance of neut rophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients[J].Crit Care,2014,18(1):r39.

[27]SONG LL,ZHAO J,YU JY,et al.Up-regulation effect of cyclosporine A on level of kidney injury molealle-Ⅰin culture supernatant of human kidney cells and its mechanism[J].J Jilin Univ:Med Edit,2014,40(6):1201-1205.(in Chinese)宋莲莲,赵军,于金宇,等.环孢素引起肾小管上皮细胞培养液中肾损伤分子-Ⅰ水平升高的机制[J].吉林大学学报:医学版,2014,40(6):1201-1205.

[28]OBERMLLER N,GEIGER H,WEIPERT C,et al.Current developments in early diagnosis of acute kidney injury[J].Int Urol Nephrol,2014,46(1):1-7.

[29]HOLZSCHEITER L,BECK C,RUTZ S,et al.NGAL,L-FABP,and KIM-1 in comparison to established markers of renal dysfunction[J].Clin Chem Lab Med,2014,52(4):537-546.

[30]HAZLE MA,GAJARSKI RJ,AIYAGARI R,et al.Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6monhs of age[J].J Thorac Cardiovasc Sury,2013,146(4):861-867.

[31]LUO JH,WU N.Value of serum kidney injury molecule-1 level in early predicting renal dysfunction seconary to liver cirrhosis[J].Lab Med Clin,2015,12(2):188-190.

[32]VIVIER PH,STOREY P,RUSINEK H,et al.Kidney function:glomerular filtration rate measurement with MR renography in patients with cirrhosis[J].Radiology,2011,259(2):462-470.

[33]GUO SB,DUAN ZJ,LI Q,et al.Effect of heme oxygenase-1 on renalfunction in rats with liver cirrhosis[J].World J Gastroenterol,2011,17(3):322-328.

[34]ARAKI S,HANEDA M,KOYA D,et al.Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without ad vanced nephropath[J].Diabetes Care,2013,36(5):1248-1253.

[35]YONG K,OOI EM,DOGRA G,et al.Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial tiffness[J].Cytokine,2013,64(1):39-42.

施引文献

资源附件(0)

访问统计